NIDA grant supports Epivario’s work on epigenetic regulator for opioid use disorder
Oct. 2, 2024
Epivario Inc. has been awarded a small business innovation research (SBIR) grant of $275,000 from the National Institute on Drug Abuse (NIDA) to advance research toward the development of a novel epigenetic regulator as a treatment for opioid use disorder.